These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 14064913)

  • 21. Bacteriophage susceptibility and cultural characteristics of BCG and other tubercle bacilli.
    FROMAN S; WILL DW; BLISSE A; CONDE LJ; KRASNOW I; BOGEN E
    Dis Chest; 1955 Oct; 28(4):377-90. PubMed ID: 13261860
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of extracts of tubercle bacilli and BCG as immunizing agents in guinea pigs.
    SMITH DW; KUBICA GP
    Proc Soc Exp Biol Med; 1955 Dec; 90(3):629-35. PubMed ID: 13289857
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative antigenic potency of killed irradiated tubercle bacilli and living BCG vaccine.
    BIRKHAUG K; DARRICARRERE R
    Proc Soc Exp Biol Med; 1952 Mar; 79(3):387-90. PubMed ID: 14920438
    [No Abstract]   [Full Text] [Related]  

  • 24. [Demonstration of tubercle bacilli in organs of children who died some time after oral administration of BCG vaccine].
    VALLEJO JL
    Medicina (Mex); 1950 Sep; 30(612):387-90. PubMed ID: 14775369
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental study of BCG and urea-treated tubercle bacilli].
    AUFDERMAUR M; BRODHAGE H
    Schweiz Z Pathol Bakteriol; 1955; 18(6):1237-43. PubMed ID: 13337295
    [No Abstract]   [Full Text] [Related]  

  • 26. [Utilization of radiocarbon-labeled bovine and human tubercle bacilli for the comparative study of the efficacy of freeze-dried BCG vaccines of different origins, injected by different routes].
    PASQUIER JF; KURYLOWICZ W
    C R Seances Soc Biol Fil; 1956; 150(2):281-4. PubMed ID: 13343653
    [No Abstract]   [Full Text] [Related]  

  • 27. [SURVIVAL AND MULTIPLICATION OF BCG AND OF THE TUBERCLE BACILLUS IN MICE. III. COMPARISON OF BRAZILIAN, CANADIAN, DANISH, FRENCH, JAPANESE AND RUSSIAN DAUGHTER STRAINS].
    LY-THANH-DANG ; BENOIT JC; PANISSET M; FRAPPIER A
    Acta Tuberc Pneumol Scand; 1963; 43():113-24. PubMed ID: 14061578
    [No Abstract]   [Full Text] [Related]  

  • 28. HISTOPATHOLOGIC STUDIES AFTER BOOSTER EXPERIMENTS WITH PPD IN EXPERIMENTAL TUBERCULOUS INFECTION.
    DAHLSTROEM G; FAGRAEUS A
    Acta Tuberc Pneumol Scand Suppl; 1964; 56():SUPPL 56:118+. PubMed ID: 14162299
    [No Abstract]   [Full Text] [Related]  

  • 29. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK; Verma I; Khuller GK
    J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [PRIMARY CUTANEOUS TUBERCULOSIS].
    MERLET L; GORENA M
    Rev Chil Pediatr; 1963 Nov; 34():853-4. PubMed ID: 14124384
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of immunities against tuberculosis between the guinea pigs treated with dead tubercle bacilli paraffin-oil vaccine and those treated with BCG, by the method of slide cell culture.
    YAMADA S
    Sci Rep Res Inst Tohoku Univ Med; 1952 Mar; 3(3):333-48. PubMed ID: 14958412
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunization with the vole bacillus; the protective value of the vole bacillus (Wells) as compared with BCG against tuberculous infection.
    BIRKHAUG K
    Am Rev Tuberc; 1946 May; 53():411-26. PubMed ID: 20984406
    [No Abstract]   [Full Text] [Related]  

  • 33. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
    Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
    Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On a criterion proposed for discoverin infection with virulent tubercle bacilli after BCG vaccination].
    KOBAYASHI Y; TERAMURA F; FUKUDA H; TATEISHI K; MIKAWA H; AKAISHI K; YOKOYAMA T
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1962 Sep; 11():62-74. PubMed ID: 14033958
    [No Abstract]   [Full Text] [Related]  

  • 36. Fate of tubercle bacilli in lipopoly-saccharide- and BCG-treated mice.
    KOCHAN I; ROSE SR
    J Bacteriol; 1962 Aug; 84(2):291-4. PubMed ID: 14457583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance of guinea pigs to infection with small numbers of virulent tubercle bacilli mixed with BCG.
    YEGIAN D; BUDD V
    Am Rev Tuberc; 1955 Oct; 72(4):539-42. PubMed ID: 13259075
    [No Abstract]   [Full Text] [Related]  

  • 38. [Behavior of the golden hamster inoculated with BCG vaccine and with strains of homologous tubercle bacilli].
    VIALLIER J; CAYRE RM
    C R Seances Soc Biol Fil; 1955 Nov; 149(21-22):1991-3. PubMed ID: 13317273
    [No Abstract]   [Full Text] [Related]  

  • 39. [The dimensions of the germs composing the vaccine BCG according to the maintenance medium; its importance for the dosage of vaccine].
    VAN DEINSE F; SEYS R; MACHOLDA F
    Ann Inst Pasteur (Paris); 1950 May; 78(5):596-601. PubMed ID: 15425945
    [No Abstract]   [Full Text] [Related]  

  • 40. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.